Evidence map›Paper›PMID 38634982›Full record

ArticleCancer immunology, immunotherapy : CII2024

Correction to: Dominant‑negative transforming growth factor‑β receptor‑armoured mesothelin‑targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer.

Ke Li, Jing Xu, Jing Wang, Chong Lu, Yilin Dai, Qing Dai, Wang Zhang, Congjian Xu, Shu Wu, Yu Kang

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ke LiDepartment of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University, No. 419 Fangxie Road, Shanghai, 200011, China.
Jing XuDepartment of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University, No. 419 Fangxie Road, Shanghai, 200011, China.
Jing WangDepartment of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University, No. 419 Fangxie Road, Shanghai, 200011, China.
Chong LuDepartment of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University, No. 419 Fangxie Road, Shanghai, 200011, China.
Yilin DaiDepartment of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University, No. 419 Fangxie Road, Shanghai, 200011, China.
Qing DaiNanjing Legend Biotechnology Co., Ltd., 568 Longmian Avenue, Ltd. Life Science TechTown, Jiangning, Nanjing, 211100, China.
Wang ZhangNanjing Legend Biotechnology Co., Ltd., 568 Longmian Avenue, Ltd. Life Science TechTown, Jiangning, Nanjing, 211100, China.
Congjian XuDepartment of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University, No. 419 Fangxie Road, Shanghai, 200011, China.
Shu WuNanjing Legend Biotechnology Co., Ltd., 568 Longmian Avenue, Ltd. Life Science TechTown, Jiangning, Nanjing, 211100, China. Simon.Wu@legendbiotech.com.
Yu KangDepartment of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University, No. 419 Fangxie Road, Shanghai, 200011, China. yukang@fudan.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38634982
PMCPMC11026349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.